Cogent Biosciences (COGT)
(Delayed Data from NSDQ)
$11.11 USD
+0.56 (5.31%)
Updated Oct 4, 2024 04:00 PM ET
After-Market: $11.10 -0.01 (-0.09%) 7:58 PM ET
3-Hold of 5 3
D Value C Growth D Momentum D VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 11/7/24 |
---|---|
Current Quarter | -0.55 |
EPS Last Quarter | -0.59 |
Last EPS Surprise | -7.27% |
ABR | 1.45 |
Earnings ESP
|
0.00% |
---|---|
Current Year | -2.25 |
Next Year | -2.15 |
EPS (TTM) | -2.48 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | NA | NA | NA | NA |
# of Estimates | NA | NA | NA | NA |
High Estimate | NA | NA | NA | NA |
Low Estimate | NA | NA | NA | NA |
Year ago Sales | 0.00M | 0.00M | NA | NA |
Year over Year Growth Est. | NA | NA | NA | NA |
Earnings Estimates
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -0.55 | -0.56 | -2.25 | -2.15 |
# of Estimates | 7 | 7 | 7 | 6 |
Most Recent Consensus | -0.57 | -0.59 | -2.37 | -2.56 |
High Estimate | -0.44 | -0.43 | -1.99 | -1.59 |
Low Estimate | -0.67 | -0.69 | -2.56 | -2.82 |
Year ago EPS | -0.64 | -0.63 | -2.42 | -2.25 |
Year over Year Growth Est. | 14.06% | 11.11% | 7.02% | 4.17% |
Agreement - Estimate Revisions
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 0 | 0 | 0 | 0 |
Up Last 60 Days | 3 | 2 | 3 | 2 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 0 | 0 | 0 | 0 |
Down Last 60 Days | 3 | 4 | 3 | 3 |
Magnitude - Consensus Estimate Trend
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -0.55 | -0.56 | -2.25 | -2.15 |
7 Days Ago | -0.55 | -0.56 | -2.25 | -2.15 |
30 Days Ago | -0.55 | -0.56 | -2.25 | -2.15 |
60 Days Ago | -0.54 | -0.54 | -2.19 | -2.04 |
90 Days Ago | -0.54 | -0.54 | -2.19 | -2.04 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -0.55 | -0.56 | -2.25 | -2.15 |
Zacks Consensus Estimate | -0.55 | -0.56 | -2.25 | -2.15 |
Earnings ESP | 0.00% | 0.00% | 0.00% | 0.00% |
Surprise - Reported Earnings History
Quarter Ending (6/2024) |
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -0.59 | -0.62 | -0.63 | -0.64 | NA |
Estimate | -0.55 | -0.50 | -0.54 | -0.50 | NA |
Difference | -0.04 | -0.12 | -0.09 | -0.14 | -0.10 |
Surprise | -7.27% | -24.00% | -16.67% | -28.00% | -18.99% |
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more